Jutta Müller-Derlich

Title: Jutta Müller-Derlich: Innovator in Cardiomyopathy Treatment

Introduction

Jutta Müller-Derlich is a prominent inventor based in Germering, Germany. She has made significant contributions to the field of cardiology, particularly in the treatment of cardiomyopathy. Her innovative approach focuses on the removal of harmful autoantibodies from patients' plasma, which can lead to improved cardiac function.

Latest Patents

Jutta holds a patent for a groundbreaking method titled "Treatment of Cardiomyopathy by Removal of Autoantibodies." This immunoapheresis treatment involves passing the patient's plasma over a column that has a specific ligand for human immunoglobulin. This process effectively removes a significant portion of the immunoglobulin from the patient's plasma before reinfusing it back into the patient. The invention utilizes a specific ligand that binds and removes harmful human autoantibodies, which can damage cardiac tissue. The treatment has shown to improve various hemodynamic parameters, including mean arterial pressure and cardiac output.

Career Highlights

Throughout her career, Jutta has worked with notable companies such as Edwards Lifesciences Corporation and Reinke, Petra. Her work has been instrumental in advancing medical treatments for heart conditions, showcasing her dedication to improving patient outcomes.

Collaborations

Jutta has collaborated with esteemed colleagues, including Robert Koll and Stephan Felix. These partnerships have further enriched her research and development efforts in the medical field.

Conclusion

Jutta Müller-Derlich's innovative work in the treatment of cardiomyopathy exemplifies her commitment to advancing medical science. Her patent for immunoapheresis treatment represents a significant step forward in cardiac care.